A novel strategy for inducing enhanced mucosal HIV-1 antibody responses in an anti-inflammatory environment
Prophylactic vaccination against HIV-1 sexual transmission will probably require antibody elicitation at genital mucosal surfaces. However, HIV-1 envelope glycoprotein (Env)-based antigens are weakly immunogenic, particularly when applied mucosally. The polyanion PRO 2000 is safe for human vaginal a...
Autors principals: | Wegmann, F, Krashias, G, Lühn, K, Laamanen, K, Vieira, S, Jeffs, S, Shattock, R, Sattentau, Q |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
Public Library of Science
2011
|
Matèries: |
Ítems similars
-
A novel strategy for inducing enhanced mucosal HIV-1 antibody responses in an anti-inflammatory environment.
per: Wegmann, F, et al.
Publicat: (2011) -
A novel strategy for inducing enhanced mucosal HIV-1 antibody responses in an anti-inflammatory environment.
per: Frank Wegmann, et al.
Publicat: (2011-01-01) -
The regulated secretory pathway in CD4+ T cells contributes to human immunodeficiency virus type-1 cell-to-cell spread at the virological synapse
per: Jolly, C, et al.
Publicat: (2011) -
Immunogenicity of HIV-1 gp140 - microbicide mixtures in mice using a vaginal delivery model
per: Wegmann, F, et al.
Publicat: (2007) -
Transportin 3 promotes a nuclear maturation step required for efficient HIV-1 integration
per: Zhou, L, et al.
Publicat: (2011)